Shares of Stratec SE (ETR:SBS – Get Free Report) shot up 1.4% during mid-day trading on Tuesday . The company traded as high as €18.48 and last traded at €18.46. Approximately 3,704 shares were traded during mid-day trading, a decline of 41% from the average session volume of 6,253 shares. The stock had previously closed at €18.20.
Stratec Stock Up 1.4%
The business’s 50 day simple moving average is €17.51 and its 200-day simple moving average is €19.46. The company has a debt-to-equity ratio of 49.40, a quick ratio of 1.65 and a current ratio of 4.33. The company has a market cap of $221.77 million, a price-to-earnings ratio of 22.15, a price-to-earnings-growth ratio of 10.43 and a beta of 0.80.
Stratec Company Profile
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Featured Articles
- Five stocks we like better than Stratec
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
